C1QTNF9 and obstructive sleep apnea syndrome: These findings provide evidence that CTRP9 and its related signaling maybe a novel therapeutic target in improving cardiac function and alleviating the heart failure (HF) phenotype in MI patients with obstructive sleep apnea (OSA).